107 related articles for article (PubMed ID: 21388255)
1. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer.
Costantini C; Ale-Ali A; Helsten T
J Palliat Med; 2011 May; 14(5):563-6. PubMed ID: 21388255
[TBL] [Abstract][Full Text] [Related]
2. Sleep aid use during and following breast cancer adjuvant chemotherapy.
Moore TA; Berger AM; Dizona P
Psychooncology; 2011 Mar; 20(3):321-5. PubMed ID: 20878849
[TBL] [Abstract][Full Text] [Related]
3. Febrile neutropaenia and chemotherapy discontinuation in women aged 70 years or older receiving adjuvant chemotherapy for early breast cancer.
Adjogatse D; Thanopoulou E; Okines A; Thillai K; Tasker F; Johnston SR; Harper-Wynne C; Torrisi E; Ring A
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):692-6. PubMed ID: 24909701
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer.
Kennedy CR; Gao F; Margenthaler JA
J Surg Res; 2010 Sep; 163(1):52-7. PubMed ID: 20599225
[TBL] [Abstract][Full Text] [Related]
5. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
Wielgus KK; Berger AM; Hertzog M
Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Gianni L; Eiermann W; Semiglazov V; Manikhas A; Lluch A; Tjulandin S; Zambetti M; Vazquez F; Byakhow M; Lichinitser M; Climent MA; Ciruelos E; Ojeda B; Mansutti M; Bozhok A; Baronio R; Feyereislova A; Barton C; Valagussa P; Baselga J
Lancet; 2010 Jan; 375(9712):377-84. PubMed ID: 20113825
[TBL] [Abstract][Full Text] [Related]
7. Inpatient pharmacological sleep aid utilization is common at a tertiary medical center.
Gillis CM; Poyant JO; Degrado JR; Ye L; Anger KE; Owens RL
J Hosp Med; 2014 Oct; 9(10):652-7. PubMed ID: 25130534
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sleep pattern disorders in breast cancer patients receiving adjuvant treatment (chemotherapy and/or radiotherapy) using polysomnography.
Tag Eldin ES; Younis SG; Aziz LMAE; Eldin AT; Erfan ST
J BUON; 2019; 24(2):529-534. PubMed ID: 31128001
[TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity in performing chemotherapy of breast cancer by the data of retrospective multicenter "case-control" investigation].
Vel'sher LZ; Kaziulin AN; Koroleva IA
Vestn Khir Im I I Grek; 2010; 169(4):17-21. PubMed ID: 20973179
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database.
Killelea BK; Yang VQ; Mougalian S; Horowitz NR; Pusztai L; Chagpar AB; Lannin DR
J Am Coll Surg; 2015 Jun; 220(6):1063-9. PubMed ID: 25868410
[TBL] [Abstract][Full Text] [Related]
12. Are depression and poor sleep quality a major problem in Turkish Women receiving chemotherapy for breast cancer?
Buyuksimsek M; Gulmez A; Pirinci O; Tohumcuoglu M; Kidi MM
Rev Assoc Med Bras (1992); 2024; 70(3):e20231377. PubMed ID: 38656011
[TBL] [Abstract][Full Text] [Related]
13. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB.
Kim R; Osaki A; Tanabe K; Toge T
Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565
[TBL] [Abstract][Full Text] [Related]
15. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study.
Berger AM; VonEssen S; Kuhn BR; Piper BF; Agrawal S; Lynch JC; Higginbotham P
Oncol Nurs Forum; 2003; 30(3):513-22. PubMed ID: 12719750
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.
Choi MK; Park YH; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2014 Sep; 74(3):521-9. PubMed ID: 25047725
[TBL] [Abstract][Full Text] [Related]
19. Alterations and Interdependence in Self-Reported Sleep-Wake Parameters of Patient-Caregiver Dyads During Adjuvant Chemotherapy for Breast Cancer
.
Kotronoulas G; Wengström Y; Kearney N
Oncol Nurs Forum; 2016 May; 43(3):288-301. PubMed ID: 27105191
[TBL] [Abstract][Full Text] [Related]
20. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.
Ancoli-Israel S; Liu L; Marler MR; Parker BA; Jones V; Sadler GR; Dimsdale J; Cohen-Zion M; Fiorentino L
Support Care Cancer; 2006 Mar; 14(3):201-9. PubMed ID: 16010529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
